Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-03 Purchase | 2019-12-03 6:32 pm | Protagonist Therapeutics Inc | PTGX | Gupta Suneel EVP Clinical Operations | 30,000 | $5.13 | $153,900 | 49,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-19 Exercise | 2023-10-23 4:31 pm | N/A 2029-01-14 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 20,000 | $0 | 218,317 (Direct) | View |
| 2023-10-19 Exercise | 2023-10-23 4:31 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 20,000 | $7.38 | 218,317 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 7:51 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 12,000 | $0 | 148,037 (Direct) | View |
| 2023-05-31 Tax Withholding | 2023-06-02 7:51 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 4,150 | $26.07 | 148,037 (Direct) | View |
| 2023-01-16 Option Award | 2023-01-18 7:56 pm | N/A 2033-01-15 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 144,375 | $0 | 261,937 (Direct) | View |
| 2022-04-26 Exercise | 2022-04-26 9:42 pm | N/A 2029-01-14 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 40,000 | $0 | 187,561 (Direct) | View |
| 2022-04-26 Exercise | 2022-04-26 9:42 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 40,000 | $7.38 | 187,561 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-03-02 8:40 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 649 | $24.28 | 77,007 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 7:24 pm | N/A 2032-02-14 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 87,500 | $0 | 152,656 (Direct) | View |
| 2021-02-26 Option Award | 2021-02-26 6:27 pm | N/A 2031-02-25 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 92,000 | $0 | 143,987 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 5:44 pm | N/A 2030-02-27 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel Chief Development Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-04 6:27 pm | N/A 2029-02-27 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel EVP Clinical Operations | 52,500 | $0 | 62,500 (Direct) | View |
| 2019-01-15 Exercise | 2019-01-16 6:42 pm | N/A 2029-01-14 | Protagonist Therapeutics Inc | PTGX | Gupta Suneel EVP Clinical Operations | 110,000 | $0 | 110,000 (Direct) | View |
Ownership | 2019-01-09 6:08 pm | N/A N/A | Protagonist Therapeutics Inc | PTGX | Gupta Suneel EVP Clinical Operations | 0 | $0 | 10,000 (Direct) | View |